BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37795080)

  • 1. GPX8 regulates pan-apoptosis in gliomas to promote microglial migration and mediate immunotherapy responses.
    Chen Z; Zheng D; Lin Z; Zhang C; Wei C; Deng X; Yan P; Zheng C; Lan C; Qin C; Wei X; Qin D; Wu Y; Peng J; Miao C; Lu L; Xia Y; Luo Q
    Front Immunol; 2023; 14():1260169. PubMed ID: 37795080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GPX8 as a Novel Prognostic Factor and Potential Therapeutic Target in Primary Glioma.
    Yang ZS; Yang Q; Sun XX; Xiong K; Zhu XT; Wang YC; Ren QY; Wu GH; Wang SM; Cao XQ; Yang XR; Jiang WG
    J Immunol Res; 2022; 2022():8025055. PubMed ID: 36052280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune Infiltrating Cells-Derived Risk Signature Based on Large-scale Analysis Defines Immune Landscape and Predicts Immunotherapy Responses in Glioma Tumor Microenvironment.
    Zhang N; Zhang H; Wang Z; Dai Z; Zhang X; Cheng Q; Liu Z
    Front Immunol; 2021; 12():691811. PubMed ID: 34489938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single cell RNA sequencing reveals differentiation related genes with drawing implications in predicting prognosis and immunotherapy response in gliomas.
    Zhou Z; Wei J; Yang Z; Bao Y; Jiang W; Lu B; Wang W; Li L
    Sci Rep; 2022 Feb; 12(1):1872. PubMed ID: 35115572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas.
    Wei C; Wang B; Peng D; Zhang X; Li Z; Luo L; He Y; Liang H; Du X; Li S; Zhang S; Zhang Z; Han L; Zhang J
    Front Immunol; 2022; 13():849592. PubMed ID: 35444654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicellular gene network analysis identifies a macrophage-related gene signature predictive of therapeutic response and prognosis of gliomas.
    Sun X; Liu X; Xia M; Shao Y; Zhang XD
    J Transl Med; 2019 May; 17(1):159. PubMed ID: 31097021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGFBP2 from a novel copper metabolism-associated biomarker promoted glioma progression and response to immunotherapy.
    Luo Q; Zhuang J; Zheng D; Miao C; Luo H; Peng J; Zheng C; Qin C; Lan C; Chen M; Xia Y; Huang D; Chen Z
    Front Immunol; 2023; 14():1282734. PubMed ID: 37928523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of cancer immunotherapy through pyroptosis: A pyroptosis-related signature predicts survival benefit and potential synergy for immunotherapy in glioma.
    Zeng Y; Cai Y; Chai P; Mao Y; Chen Y; Wang L; Zeng K; Zhan Z; Xie Y; Li C; Zhan H; Zhao L; Chen X; Zhu X; Liu Y; Chen M; Song Y; Zhou A
    Front Immunol; 2022; 13():961933. PubMed ID: 35990696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen processing and presentation-related signature-derived BNIP3 is a novel oncogene and immunotherapy determinant in osteosarcoma based on machine learning and in vitro validation.
    Chen Y; Cao Y; Wu S; Cao X; Cai T; Hu H
    J Gene Med; 2024 Jan; 26(1):e3586. PubMed ID: 37655535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyroptosis: a novel signature to predict prognosis and immunotherapy response in gliomas.
    He G; Chen Z; Zhuo S; Tang J; Hao W; Yang K; Yang C
    Hum Cell; 2022 Nov; 35(6):1976-1992. PubMed ID: 36129672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment.
    Müller S; Kohanbash G; Liu SJ; Alvarado B; Carrera D; Bhaduri A; Watchmaker PB; Yagnik G; Di Lullo E; Malatesta M; Amankulor NM; Kriegstein AR; Lim DA; Aghi M; Okada H; Diaz A
    Genome Biol; 2017 Dec; 18(1):234. PubMed ID: 29262845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RUNX1/CD44 axis regulates the proliferation, migration, and immunotherapy of gliomas: A single-cell sequencing analysis.
    Zhang H; Cao H; Luo H; Zhang N; Wang Z; Dai Z; Wu W; Liu G; Xie Z; Cheng Q; Cheng Y
    Front Immunol; 2023; 14():1086280. PubMed ID: 36776876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen Presentation Machinery Signature-Derived CALR Mediates Migration, Polarization of Macrophages in Glioma and Predicts Immunotherapy Response.
    Chen R; Zhang H; Wu W; Li S; Wang Z; Dai Z; Liu Z; Zhang J; Luo P; Xia Z; Cheng Q
    Front Immunol; 2022; 13():833792. PubMed ID: 35418980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GPX8 promotes migration and invasion by regulating epithelial characteristics in non-small cell lung cancer.
    Zhang J; Liu Y; Guo Y; Zhao Q
    Thorac Cancer; 2020 Nov; 11(11):3299-3308. PubMed ID: 32975378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Comprehensive Analysis of the Glutathione Peroxidase 8 (GPX8) in Human Cancer.
    Ren Z; He Y; Yang Q; Guo J; Huang H; Li B; Wang D; Yang Z; Tian X
    Front Oncol; 2022; 12():812811. PubMed ID: 35402257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Immune Infiltrating Cell Signature Based on Cell Pair Algorithm Is a Prognostic Marker in Cancer.
    Zhang H; Wang Z; Dai Z; Wu W; Cao H; Li S; Zhang N; Cheng Q
    Front Immunol; 2021; 12():694490. PubMed ID: 34594324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microglial Exosome miR-7239-3p Promotes Glioma Progression by Regulating Circadian Genes.
    Li X; Guan J; Jiang Z; Cheng S; Hou W; Yao J; Wang Z
    Neurosci Bull; 2021 Apr; 37(4):497-510. PubMed ID: 33528793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification related to immunogenic cell death predicts prognosis, immune microenvironment characteristics, and response to immunotherapy in lower-grade gliomas.
    Kuang Y; Jiang B; Zhu H; Zhou Y; Huang H; Li C; Zhang W; Li X; Cao Y
    Front Immunol; 2023; 14():1102094. PubMed ID: 37153540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential of IDH mutations as immunotherapeutic targets in gliomas: a review and meta-analysis.
    Gonzalez N; Asad AS; Gómez Escalante J; Peña Agudelo JA; Nicola Candia AJ; García Fallit M; Seilicovich A; Candolfi M
    Expert Opin Ther Targets; 2021 Dec; 25(12):1045-1060. PubMed ID: 34904924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenic cell death-related risk signature predicts prognosis and characterizes the tumour microenvironment in lower-grade glioma.
    Cai J; Hu Y; Ye Z; Ye L; Gao L; Wang Y; Sun Q; Tong S; Yang J; Chen Q
    Front Immunol; 2022; 13():1011757. PubMed ID: 36325335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.